Endoscopy study comparing risedronate and alendronate in postmenopausal women.

被引：1
|
作者：
Lanza, FL
Hunt, RH
Thomson, AB
Provenza, M
Blank, MA
机构：
[1] Houston Inst Clin Res, Risedronate Endoscopy Study Grp, Houston, TX USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] Univ Alberta, Edmonton, AB, Canada
[4] Gastrointestinal Specialists, Shreveport, LA USA
[5] Procter & Gamble, Cincinnati, OH USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84013-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2572
引用
收藏
页码：A474 / A474
页数：1
相关论文
共 50 条
  • [1] Tolerability of risedronate in alendronate-intolerant postmenopausal women.
    Adachi, JD
    Adami, S
    Miller, PD
    Olszynski, WP
    Kendler, DL
    Silverman, SL
    Licata, A
    Li, Z
    Stevens, KP
    Horlait, S
    Long, PH
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S202 - S202
  • [2] 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status
    Thomson, ABR
    Marshall, JK
    Hunt, RH
    Provenza, JM
    Lanza, FL
    Royer, MG
    Li, ZQ
    Blank, MA
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (09) : 1965 - 1974
  • [3] Follow-up endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by H. pylori status
    Thomson, ABR
    Marshall, JK
    Hunt, RH
    Lanza, FL
    Blank, MA
    [J]. BONE, 2001, 28 (05) : S222 - S222
  • [4] Risedronate is well-tolerated in alendronate-intolerant postmenopausal women.
    Adachi, J
    Adami, S
    Miller, P
    Olszynski, WP
    Kendler, D
    Silverman, S
    Licata, A
    Li, Z
    Stevens, K
    Long, PH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S429 - S429
  • [5] Tolerability of risedronate in postmenopausal women intolerant of alendronate
    J. D. Adachi
    S. Adami
    P. D. Miller
    W. P. Olszynski
    D. L. Kendler
    S. L. Silverman
    A. A. Licata
    Z. Li
    E. Gomez-Panzani
    [J]. Aging Clinical and Experimental Research, 2001, 13 : 347 - 354
  • [6] Tolerability of risedronate in postmenopausal women intolerant of alendronate
    Adachi, JD
    Adami, S
    Miller, PD
    Olszynski, WP
    Kendler, DL
    Silverman, SL
    Licata, AA
    Li, Z
    Gomez-Panzani, E
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (05) : 347 - 354
  • [7] The efficacy of Alendronate in postmenopausal osteoporotic women.
    Bernad, M
    Del Campo, T
    Gonzalez, M
    Fernandez, J
    Garces, M
    Martin-Mola, E
    Martinez, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
  • [8] Effects of discontinuation of alendronate in early postmenopausal women.
    Fuleihan, GE
    Luckey, M
    Bauer, R
    Wasnich, R
    Krupa, D
    Reda, C
    Yates, AJ
    Daifotis, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 164 - 164
  • [9] Satisfaction, preference and compliance with alendronate and risedronate in postmenopausal women with osteoporosis
    Pérez, LI
    Sanidefonso, MM
    Paleo, EE
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S42 - S42
  • [10] Reduction of osteoporotic fractures with risedronate in osteopenic postmenopausal women.
    Siris, ES
    Barton, IP
    McClung, MR
    Grauer, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S93 - S93
12345